I agree that this site is using cookies. You can find further informations here.
X
Llamas‐Velasco, Mar
176  results:
Search for persons X
?
1

Age affects drug survival rates of interleukin (IL)‐17 and ..:

Chiricozzi, Andrea ; Coscarella, Giulia ; Puig, Luis...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Ustekinumab is effective and safe in the long‐term treatmen..:

Plana, Clara ; Concha‐Garzón, Maria J. ; Rocamora, Vicen C....
JEADV Clinical Practice.  3 (2024)  2 - p. 604-610 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Certolizumab pegol effectiveness, survival and safety in pa..:

Sahuquillo‐Torralba, Antonio ; Mansilla‐Polo, Miguel ; Pujol‐Marco, Conrad...
International Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Dose reduction is a feasible strategy in patients with plaq..:

Daudén, Esteban ; Escario, Elena ; Martos‐Cabrera, Luisa...
International Journal of Dermatology.  63 (2024)  4 - p. 503-511 , 2024
Link: https://doi.org/10.1111/..
 
?
5

Can we treat anti‐PD1 induced psoriasis in patients with ac..:

Rodríguez‐Jiménez, Pedro ; Ibarguren, Ander Mayor ; Butrón‐Bris, Beatriz..
JEADV Clinical Practice.  2 (2023)  2 - p. 379-381 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Tildrakizumab improves high burden skin symptoms, impaired ..:

Costanzo, Antonio ; Llamas‐Velasco, Mar ; Fabbrocini, Gabriella...
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  10 - p. 2004-2015 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Effectiveness and safety of tildrakizumab for the treatment..:

Berenguer‐Ruiz, Sonsoles ; Aparicio‐Domínguez, Mario ; Herranz‐Pinto, Pedro...
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  12 - p. 2517-2525 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Apremilast treatment of plaque psoriasis (PsO) after system..:

de la Cueva, Pablo ; Armesto, Susana ; Montesinos, Encarnacion...
JEADV Clinical Practice.  2 (2023)  3 - p. 488-501 , 2023
Link: https://doi.org/10.1002/..
 
?
9

First experiences in real clinical practice treating a pati..:

Fernández‐Galván, Aurora ; Daudén, Esteban ; Butron‐Bris, Beatriz...
JEADV Clinical Practice.  2 (2023)  2 - p. 369-372 , 2023
Link: https://doi.org/10.1002/..
 
?
10

High adherence to secukinumab in patients with moderate to ..:

Martos‐Cabrera, Luisa ; Llamas‐Velasco, Mar ; Armesto, Susana...
International Journal of Dermatology.  62 (2022)  3 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
11

Dermal lipofibromatosis‐like neural tumor:

Llamas‐Velasco, Mar ; Itlinger‐Monshi, Babak ; Flucke, Uta.
Journal of Cutaneous Pathology.  49 (2022)  6 - p. 525-531 , 2022
Link: https://doi.org/10.1111/..
 
?
12

Fast and sustained improvement of patient‐reported outcomes..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  8 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
13

Ustekinumab to guselkumab transitions: A series of 54 patie..:

Berenguer‐Ruiz, Sonsoles ; Rivera, Raquel ; Herranz, Pedro...
Dermatologic Therapy.  35 (2022)  10 - p. , 2022
Link: https://doi.org/10.1111/..
 
?
14

Cutaneous vascular calcification. Perieccrine calcification..:

Reolid, Alejandra ; Martínez‐Palazuelo, María ; Rodríguez‐Jiménez, Pedro...
Journal of Cutaneous Pathology.  49 (2022)  8 - p. 683-691 , 2022
Link: https://doi.org/10.1111/..
 
?
15

Secukinumab is effective and safe in the long‐term treatmen..:

Chicharro, Pablo ; Llamas‐Velasco, Mar ; Armesto, Susana...
Dermatologic Therapy.  35 (2022)  12 - p. , 2022
Link: https://doi.org/10.1111/..
 
1-15